Natural killer T cells in patients with prostatic carcinoma

Urologia Internationalis

Volumn 71, Issue 2, 2003, Pages 146-149

  Schwemmer, Bernhard ^a  

^a NONE   (Germany)

Author keywords

Androgen withdrawal; CD8+ cells; MHC non restricted cytotoxicity; Natural killer cells; Natural killer T cells; NKT cells; Prostatic carcinoma

Indexed keywords

ANDROGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD LEVEL; CANCER PATIENT; CELL FUNCTION; COMPARATIVE STUDY; CORRELATION ANALYSIS; DRUG WITHDRAWAL; HELPER CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CARCINOMA; REGULATORY MECHANISM;

CD8-POSITIVE T-LYMPHOCYTES; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; PROSTATIC NEOPLASMS; T-LYMPHOCYTES;

EID: 0041664916     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071836     Document Type: Article

References (20)

1. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M: CD 1 d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998;188:1521-1528.
2. Percelli SA: The CD 1 family: A third lineage of antigen-presenting molecules. Adv Immunol 1995;59:1-98.
3. Hayashi A, Nishimura Y, Matsubara T: Occurrence of ceramide digalactoside in the marine sponge Halichondria japonica. Biochim Biophys Acta 1991;1083:179-186.
4. Watanabe K, Matsubara T, Hakomori S: Alpha-L-fucosylpyranosylceramide, a novel glycolipid in some of the human colon tumors. J Biol Chem 1976;251:2385-2387.
5. Joyce S: CD 1 d and natural T cells: How their properties jump-start the immune system. Cell Mol Life Sci 2001;58:442-469.
6. Hong WS, Min YI, Son YS, Hong SI: Peripheral blood lymphocyte subsets in patients with stomach cancer. J Korean Med Sci 1995;10: 164-168.
7. Mazzocolli G, Balzanelli M, Giuliani A, Cata A, La Viola M, Carella AM, Bianco G, Tarquini R: Lymphocyte subpopulation anomalies in lung cancer patients and relationship to the stage of disease. In Vivo 1999;13:205-209.
8. Markowska J, Lacki JK, Jaroszewski J, Wiktorovicz K: The usefulness of CD4/CD8 ratio evaluation in monitoring ovarian cancer patients. Eur J Gynaecol Oncol 1995;16:54-58.
9. Tahir SM, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, Wilson SB, Balk SP, Exley MA: Loss of IFN-γ production by invariant NKT cells in advanced cancer. J Immunol 2001;167: 4046-4057.
10. Oliver RT, Joseph JV, Gallagher CJ: Castration-induced lymphocytosis in prostate cancer: Possible evidence for gonad/thymus endocrine interaction in man. Urol Int 1995;54:226-229.
11. Mercader M, Bodner B, Moser MT, Kwon PS, Park ES, Manecke RG, Ellis TM, Wojcik EM, Yang D, Flanigan RC, Waters WB, Kast WM, Kwon ED: T cell infiltration of the prostate induced by androgen withdrawal in patients with prostatic cancer. Proc Natl Acad Sci USA 2001;98:14565-14579.
12. Landstrom M, Funa K: Apoptosis in rat prostatic adenocarcinoma is associated with rapid infiltration of cytotoxic T-cells and activated macrophages. Int J Cancer 1997;71:451-455.
13. Vesalainen S, Lipponen P, Talja M, Syrjanen K: Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994; 30A:1797-1803.
14. Nakagawa R, Serizawa I, Motoki K, Sato M, Ueno H, Iijima R, Nakamura H, Shimosaka A, Koezuka Y: Antitumor activity of α-galactosylceramide, KNR 7000, in mice with the melanoma B16 hepatic metastasis and immunological study of tumor infiltrating cells. Oncol Res 2000;12:51-58.
15. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, Kondo E, Harada M, Koseki H, Nakayama T, Tanaka Y, Taniguchi M: Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc Natl Acad Sci USA 1998;95:5690-5693.
16. Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, Akutsu Y, Motohashi S, Iizasa T, Endo H, Fujisawa T, Shinkai H, Taniguchi M: Antitumor cytotoxicity mediated by ligand-activated human Vα 24 NKT cells. Cancer Res 1999;59:5102-5105.
17. Timmermann JM, Levy R: Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med 1999;50:507-529.
18. Bodmer WF, Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG: Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann NY Acad Sci 1993;690:42-49.
19. Pawelec G, Zeuthen J, Kiessling R: Escape from host-antitumor immunity. Crit Rev Oncog 1997;8:111-141.
20. Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI: NKT cells-conductors of tumor immunity? Curr Opin Immunol 2002;14:165-171.